Fredric N Eshelman - Net Worth and Insider Trading

Fredric N Eshelman Net Worth

The estimated net worth of Fredric N Eshelman is at least $186 Million dollars as of 2024-02-26. Fredric N Eshelman is the Executive Chairman of The Medicines Co and owns about 2,072,920 shares of The Medicines Co (MDCO) stock worth over $176 Million. Fredric N Eshelman is the Director, 10% Owner of G1 Therapeutics Inc and owns about 3,689,151 shares of G1 Therapeutics Inc (GTHX) stock worth over $8 Million. Fredric N Eshelman is also the Director, 10% Owner of Eyenovia Inc and owns about 1,273,428 shares of Eyenovia Inc (EYEN) stock worth over $2 Million. Details can be seen in Fredric N Eshelman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Fredric N Eshelman has not made any transactions after 2018-01-29 and currently still holds the listed stock(s).

Transaction Summary of Fredric N Eshelman

To

Fredric N Eshelman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Fredric N Eshelman owns 8 companies in total, including Aravive Inc () , Eyenovia Inc () , and Liquidia Corp () among others .

Click here to see the complete history of Fredric N Eshelman’s form 4 insider trades.

Insider Ownership Summary of Fredric N Eshelman

Ticker Comapny Transaction Date Type of Owner
Aravive Inc 2020-04-08 director
Eyenovia Inc 2020-09-11 director
Liquidia Corp 2020-11-19 10 percent owner
G1 Therapeutics Inc 2017-11-13 director & 10 percent owner
Amplitude Healthcare Acquisition Corp 2019-11-19 director
The Medicines Co 2018-05-31 director & Executive Chairman
Bausch Health Companies Inc 2016-03-08 director
Jasper Therapeutics Inc 2019-11-19 director

Fredric N Eshelman Latest Holdings Summary

Fredric N Eshelman currently owns a total of 3 stocks. Among these stocks, Fredric N Eshelman owns 2,072,920 shares of The Medicines Co (MDCO) as of December 8, 2017, with a value of $176 Million and a weighting of 94.45%. Fredric N Eshelman owns 3,689,151 shares of G1 Therapeutics Inc (GTHX) as of November 13, 2017, with a value of $8 Million and a weighting of 4.4%. Fredric N Eshelman also owns 1,273,428 shares of Eyenovia Inc (EYEN) as of January 29, 2018, with a value of $2 Million and a weighting of 1.15%.

Latest Holdings of Fredric N Eshelman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MDCO The Medicines Co 2017-12-08 2,072,920 84.90 175,990,908
GTHX G1 Therapeutics Inc 2017-11-13 3,689,151 2.22 8,189,915
EYEN Eyenovia Inc 2018-01-29 1,273,428 1.69 2,152,093

Holding Weightings of Fredric N Eshelman


Fredric N Eshelman Form 4 Trading Tracker

According to the SEC Form 4 filings, Fredric N Eshelman has made a total of 0 transactions in The Medicines Co (MDCO) over the past 5 years. The most-recent trade in The Medicines Co is the acquisition of 200,000 shares on December 8, 2017, which cost Fredric N Eshelman around $5 Million.

According to the SEC Form 4 filings, Fredric N Eshelman has made a total of 0 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years. The most-recent trade in G1 Therapeutics Inc is the acquisition of 250,000 shares on November 13, 2017, which cost Fredric N Eshelman around $5 Million.

According to the SEC Form 4 filings, Fredric N Eshelman has made a total of 0 transactions in Eyenovia Inc (EYEN) over the past 5 years. The most-recent trade in Eyenovia Inc is the acquisition of 335,000 shares on January 29, 2018, which cost Fredric N Eshelman around $3 Million.

Insider Trading History of Fredric N Eshelman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Fredric N Eshelman Trading Performance

GuruFocus tracks the stock performance after each of Fredric N Eshelman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fredric N Eshelman is 13.74%. GuruFocus also compares Fredric N Eshelman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fredric N Eshelman within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Fredric N Eshelman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Fredric N Eshelman

Average Relative Return

41.13%

Average relative return per transaction

Outperforming Transactions

50%

3 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 3.06 13.74 32.71 41.13 7.2 1.9
Relative Return to S&P 500(%) 2.21 11.51 27.57 33.66 -2.46 -8.43

Fredric N Eshelman Ownership Network

Ownership Network List of Fredric N Eshelman

No Data

Ownership Network Relation of Fredric N Eshelman


Fredric N Eshelman Owned Company Details

What does Aravive Inc do?

Who are the key executives at Aravive Inc?

Fredric N Eshelman is the director of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .

Aravive Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aravive Inc Insider Transactions

No Available Data

Fredric N Eshelman Mailing Address

Above is the net worth, insider trading, and ownership report for Fredric N Eshelman. You might contact Fredric N Eshelman via mailing address: Ppd Inc, 929 North Front Street, Wilmington Nc 28401.

Discussions on Fredric N Eshelman

No discussions yet.